Table 1.

Clinical characteristics of patients with recurrent ependymoma

Patient Characteristics
N	15
n eligible	14
n evaluable	13
Median age at enrollment, y (range)	9.7 (3–19.5)
Histology	Grade II = 10, grade III = 4
n on EIACD	2
Median no. of courses (range)	3 (2–12)
Objective responses (CR + PR)	0
n cases stable disease for >12 weeks	2
n cases progressive disease	10
Median time to progression (range)	2.2 mo (1.9–6.3)
6-mo PFS (±SE)	25.7% (±11.1%)